These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 9211897)
1. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. Laccotripe M; Makrides SC; Jonas A; Zannis VI J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897 [TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding. Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835 [TBL] [Abstract][Full Text] [Related]
3. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. Cho KH; Durbin DM; Jonas A J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts. Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289 [TBL] [Abstract][Full Text] [Related]
5. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo. Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583 [TBL] [Abstract][Full Text] [Related]
6. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480 [TBL] [Abstract][Full Text] [Related]
8. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity. Sparks DL; Frank PG; Neville TA Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105 [TBL] [Abstract][Full Text] [Related]
9. Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation. Dhoest A; Zhao Z; De Geest B; Deridder E; Sillen A; Engelborghs Y; Collen D; Holvoet P J Biol Chem; 1997 Jun; 272(25):15967-72. PubMed ID: 9188498 [TBL] [Abstract][Full Text] [Related]
10. Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity. Gorshkova IN; Mei X; Atkinson D J Lipid Res; 2018 Feb; 59(2):348-356. PubMed ID: 29208698 [TBL] [Abstract][Full Text] [Related]
11. Identification of a sequence of apolipoprotein A-I associated with the activation of Lecithin:Cholesterol acyltransferase. Sviridov D; Hoang A; Sawyer WH; Fidge NH J Biol Chem; 2000 Jun; 275(26):19707-12. PubMed ID: 10781581 [TBL] [Abstract][Full Text] [Related]
12. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid. Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003 [TBL] [Abstract][Full Text] [Related]
13. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346 [TBL] [Abstract][Full Text] [Related]
14. A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein. Gu X; Wu Z; Huang Y; Wagner MA; Baleanu-Gogonea C; Mehl RA; Buffa JA; DiDonato AJ; Hazen LB; Fox PL; Gogonea V; Parks JS; DiDonato JA; Hazen SL J Biol Chem; 2016 Mar; 291(12):6386-95. PubMed ID: 26797122 [TBL] [Abstract][Full Text] [Related]
15. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
16. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins. Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952 [TBL] [Abstract][Full Text] [Related]
17. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein. Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux. Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393 [TBL] [Abstract][Full Text] [Related]
19. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase. Roosbeek S; Vanloo B; Duverger N; Caster H; Breyne J; De Beun I; Patel H; Vandekerckhove J; Shoulders C; Rosseneu M; Peelman F J Lipid Res; 2001 Jan; 42(1):31-40. PubMed ID: 11160363 [TBL] [Abstract][Full Text] [Related]